Pactiv Evergreen price target raised to $15 from $12 at Baird

Baird raised the firm’s price target on Pactiv Evergreen to $15 from $12 and keeps a Neutral rating on the shares. The firm said the operational turnaround over the past two years with related momentum over the next two years is impressive, underpinning iterative improvement in the balance sheet.